Adelaide, SA

South Australian Health and Medical Research Institute

Mental Disorders

Panic Disorder

Verapamil

Vancomycin

Telmisartan

Neomycin

Honeybrains Biotech

University of Adelaide

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The purpose of this study is to determine the safety and efficacy of HB-1, versus placebo and two monotherapies, in male and female adult patients aged 18 to 65 years, inclusive, with Panic Disorder.

Efficacy and Safety of HB-1 for Panic Disorder

South Australian Health and Medical Research Institute | Adelaide, SA

Site insights

Work at this site?

Active trials

Efficacy and Safety of HB-1 for Panic Disorder

Trial sponsors